New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback